Catalent Maryland Inc – FDA 483
An FDA inspection of Paragon Gene Therapy/Catalent Maryland Inc., a biologics/cell therapy manufacturer in Harmans, Maryland, revealed significant deficiencies across multiple areas. The firm failed to consistently follow standard operating procedures, exhibited inadequate deviation management and trending, and lacked sufficient controls to prevent material mix-ups. Additionally, issues were noted with preventing recurrence of cell culture vessel defects and establishing expiration dates for manufacturing media.
- Company
- Catalent Maryland Inc
- Product type
- biologics
ID · 6fe2c9ac-b15f-41dc-bb94-94ec7a881cd0
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.